Evidence Based Diagnosis

Slides:



Advertisements
Similar presentations
Lecture 3 Validity of screening and diagnostic tests
Advertisements

Conditional Probability
Step 3: Critically Appraising the Evidence: Statistics for Diagnosis.
Is it True? Evaluating Research about Diagnostic Tests
Critically Evaluating the Evidence: diagnosis, prognosis, and screening Elizabeth Crabtree, MPH, PhD (c) Director of Evidence-Based Practice, Quality Management.
Evaluation of Diagnostic Test Studies
Journal Club Alcohol and Health: Current Evidence September–October 2006.
CRITICAL APPRAISAL Dr. Cristina Ana Stoian Resident Journal Club
Journal Club Alcohol and Health: Current Evidence July–August 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2010.
Vanderbilt Sports Medicine Chapter 4: Prognosis Presented by: Laurie Huston and Kurt Spindler Evidence-Based Medicine How to Practice and Teach EBM.
Statistics for Health Care
By Dr. Ahmed Mostafa Assist. Prof. of anesthesia & I.C.U. Evidence-based medicine.
Sample Size Determination
Statistics in Screening/Diagnosis
Multiple Choice Questions for discussion
DEB BYNUM, MD AUGUST 2010 Evidence Based Medicine: Review of the basics.
Diagnostic Cases. Goals & Objectives Highlight Bayesian and Boolean processes used in classic diagnosis Demonstrate use/misuse of tests for screening.
EBM --- Journal Reading Presenter :李政鴻 Date : 2005/10/26.
Lecture 4: Assessing Diagnostic and Screening Tests
Statistics for Health Care Biostatistics. Phases of a Full Clinical Trial Phase I – the trial takes place after the development of a therapy and is designed.
EDRN Approaches to Biomarker Validation DMCC Statisticians Fred Hutchinson Cancer Research Center Margaret Pepe Ziding Feng, Mark Thornquist, Yingye Zheng,
Evidence Based Medicine Workshop Diagnosis March 18, 2010.
Screening and Diagnostic Testing Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public Health San Diego State University.
Previous Lecture: Data types and Representations in Molecular Biology.
EVIDENCE ABOUT DIAGNOSTIC TESTS Min H. Huang, PT, PhD, NCS.
+ Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class September 15, 2008.
Appraising A Diagnostic Test
1 Risk Assessment Tests Marina Kondratovich, Ph.D. OIVD/CDRH/FDA March 9, 2011 Molecular and Clinical Genetics Panel for Direct-to-Consumer (DTC) Genetic.
Wipanee Phupakdi, MD September 15, Overview  Define EBM  Learn steps in EBM process  Identify parts of a well-built clinical question  Discuss.
Research Strategies. Why is Research Important? Answer in complete sentences in your bell work spiral. Discuss the consequences of good or poor research.
Prediction statistics Prediction generally True and false, positives and negatives Quality of a prediction Usefulness of a prediction Prediction goes Bayesian.
Screening of diseases Dr Zhian S Ramzi Screening 1 Dr. Zhian S Ramzi.
Screening and its Useful Tools Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
Predictive values prevalence CK and acute myocardial infarction –sensitivity 70% –specificity 80% –prevalence - 40% –prevalence - 20% –PPV and NPV.
Diagnostic Tests Studies 87/3/2 “How to read a paper” workshop Kamran Yazdani, MD MPH.
Unit 15: Screening. Unit 15 Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
CLINICAL EPIDEMIOLOGY III: JOURNAL APPRAISAL Group 3 February 11, 2010.
EBM --- Journal Reading Presenter :呂宥達 Date : 2005/10/27.
Journal club Diagnostic accuracy of Urinalysis for UTI in Infants
EVALUATING u After retrieving the literature, you have to evaluate or critically appraise the evidence for its validity and applicability to your patient.
Diagnosis:Testing the Test Verma Walker Kathy Davies.
Biostatistics Board Review Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016.
Sensitivity, Specificity, and Receiver- Operator Characteristic Curves 10/10/2013.
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Critical Appraisal Course for Emergency Medicine Trainees Module 5 Evaluation of a Diagnostic Test.
Diagnosis Recitation. The Dilemma At the conclusion of my “diagnosis” presentation during the recent IAPA meeting, a gentleman from the audience asked.
Is suicide predictable? Paul St John-Smith Short Courses in Psychiatry 15/10/2008.
Copyright © 2009 Pearson Education, Inc. 4.4 Statistical Paradoxes LEARNING GOAL Investigate a few common paradoxes that arise in statistics, such as how.
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
Screening for Disease: Part One
Diagnostic studies Adrian Boyle.
DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M
Diagnostic Test Studies
Critically Appraising a Medical Journal Article
Why is Research Important?
Evidence-Based Medicine
Optimal Ways to learn about and communicate Evidence Based Medicine
Principles of Epidemiology E
How to read a paper D. Singh-Ranger.
Class session 7 Screening, validity, reliability
Understanding Results
Module 02 Research Strategies.
Diagnosis II Dr. Brent E. Faught, Ph.D. Assistant Professor
Refining Probability Test Informations Vahid Ashoorion MD. ,MSc,
Diagnosis General Guidelines:
Dr. Hannah Jordan Lecturer in Public Health ScHARR
In focus – Emerging issues in cancer control
Research Strategies.
Presentation transcript:

Evidence Based Diagnosis Hesham Al-Inany, MD Cairo University

When a Patient Has a Problem The doctor reaches a diagnosis by: Clinical data Diagnostic tools

Increasing use of investigations: - Availability Increasing use of investigations: - Availability. - The urge to make use of new technology.

Diagnostic tests The evaluation of diagnostic techniques is less advanced than that of treatments. Unlike with drugs, there are generally no formal requirements for adoption of diagnostic tests in routine care.

New Diagnostic tests The evaluation of diagnostic techniques is less advanced than that of treatments (NO phase I, II, III, IV).

This is not the only problem Patient oriented !!!!!!! Your 45 year old patient has a mammogram. The study is interpreted as "suspicious for malignancy" by your radiologist. Your patient asks you: "Does this mean I have cancer?", and you (correctly) answer "No, we have to do further testing."  

Your patient then asks, "OK, I understand that the mammogram isn't the final answer, but given what we know now, what are the chances that I have breast cancer?".

Is it Easy!!! Assume that the overall risk of breast cancer in any 45 year old woman, regardless of mammogram result, is 1%. Assume also that mammography is 90% sensitive and 95% specific. Then, select your answer below: 1%    15%      60%      85%    95%

evidence to answer questions EB Diagnosis Apply results to your patients Answerable questions clinical information needs Convert clinical information needs into answerable questions. Track down the best evidence to answer question. Critically appraise evidence for its validity and usefulness. Apply results to your clinical practice. Evaluate our performance. Find the best evidence to answer questions Understand evidence

Articles about diagnosis Relevance Validity

Relevance First, the test should be one that is feasible for you in your community Example: brain biopsy is an accurate test for diagnosing dementia, it’s not practical for my (living) patients!

Ask yourself Did the patient sample include an appropriate spectrum of patients to whom the diagnostic test will be applied in clinical practice?

Rule of Thumb at least 100 participants to ensure an appropriate "spectrum" of disease

Validity Did the authors use a gold reference standard?

A gold standard is needed. This may be a diagnostic test, however if diagnosis is to lead to treatment, a treatment outcome may be the best gold standard.

Sometimes In some cases we are limited by ethical considerations. For example, doing an invasive test such as a biopsy in a patient with a negative test result, for the sole purposes of doing a study, might be considered unethical.

So Is reference standard used acceptable? Were both reference standard and test applied to all patients?

Blinding Was there a blind comparison with the reference standard ? Frequently very difficult to achieve

Independent the decision to perform the reference standard should ideally be independent of the results of the test being studied.

Ask Yourself Did the results of the test being evaluated influence the decision to perform the reference standard?

Methodology Were the methods for performing the test described in sufficient detail to permit replication?

Statistics needed to know prevalence = probability of disease in the entire population at any point in time (i.e. 8% the Egyptian population has diabetes mellitus) incidence = probability that a patient without disease develops the disease during an interval (the incidence of diabetes mellitus is 0.6% per year, referring only to new cases)

sensitivity probability of a positive test among patients with disease i.e Ability to diagnose

specificity probability of a negative test among patients without disease i.e Ability to exclude

2 X 2 Table b (false positive) a (true positive) d (true negative) c (false negative)

Positive predictive value = probability of disease among patients with a positive test Negative predictive value = probability of no disease among patients with a negative test

Formula Definition Measure a a+c True positives All diseased Sensitivity d b+d True negatives All nondiseased Specificity a+b All screened positive Positive Predictive value c+d All screened negative Negative Predictive value

Keep in Mind sensitivity and specificity by themselves are only useful when either is very high (over typically, 95% or higher).

Likelihood Ratios LR means   probability of an individual with the condition having the test result       probability of an individual without the condition having the test result LR+ = probability of an individual with the condition having a positive test probability of an individual without the condition having a positive test

     LR- = probability of an individual with the condition having a negative test probability of an individual without the condition having a negative test LR+ = sensitivity / (1-specificity)   LR- = (1-sensitivity) / specificity

Why LR The LR+ corresponds to the clinical concept of "ruling-in disease" The LR- corresponds to the clinical concept of "ruling-out disease“

Interpreting likelihood ratios Interpretation LR Large and often conclusive increase in the likelihood of disease > 10 Moderate increase in the likelihood of disease 5 - 10 Small increase in the likelihood of disease 2 - 5 Minimal increase in the likelihood of disease 1 - 2 No change in the likelihood of disease 1 Minimal decrease in the likelihood of disease 0.5 - 1.0 Small decrease in the likelihood of disease 0.2 - 0.5 Moderate decrease in the likelihood of disease 0.1 - 0.2 Large and often conclusive decrease in the likelihood of disease < 0.1

ROC curve is simply a graph of sensitivity vs (1-specificity)

Will the results Help Me in Caring for My Patients? Finally Will the results Help Me in Caring for My Patients?

THANK YOU